Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Shuko, Harada"'
Autor:
Shuko Harada1, Mackinnon, Alexander C.1 amackinnon@uabmc.edu
Publikováno v:
Archives of Pathology & Laboratory Medicine. Feb2024, Vol. 148 Issue 2, p136-138. 3p.
Publikováno v:
Cancer Medicine, Vol 10, Iss 5, Pp 1900-1909 (2021)
Abstract Background Human papillomavirus (HPV) genotype testing has limited utility to identify human immunodeficiency virus‐infected (HIV+) women's risk for developing cervical cancer (CC) due to high positivity rate of high‐risk (HR) HPVs. We i
Externí odkaz:
https://doaj.org/article/1e15243ef4aa4e5e86e85d2b9c57bcc4
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 2, Pp 260-264 (2020)
The antiplatelet agent clopidogrel, a prodrug that requires bioactivation through the cytochrome P450 2C19 (CYP2C19) enzyme, is commonly prescribed post‐percutaneous coronary intervention (PCI). Genetic variation in CYP2C19 contributes to individua
Externí odkaz:
https://doaj.org/article/8c21fc100a76409999c2072bb3535e66
Autor:
Sydney Dunn-Valadez, Srilakshmi Bathini, Carly Elston, Sravanti Rangaraju, Antonio Di Stasi, Sarah Worth, Diana Morlote, Shuko Harada, Pankit Vachhani
Publikováno v:
Cancer Treatment and Research Communications, Vol 31, Iss , Pp 100560- (2022)
Ivosidenib is an oral inhibitor of mutant Isocitrate dehydrogenase 1 (IDH1). It is approved for treatment of patients with relapsed or refractory IDH1-mutated acute myeloid leukemia (AML) and patients with newly diagnosed IDH1-mutated AML who are 75
Externí odkaz:
https://doaj.org/article/2fa1bcd8c31444e0bc126a135dcd519a
Autor:
Deepti Dhall, Elias Makhoul, Roberto Taguibao, Kevin Waters, Wenjuan Zhang, Eric Vail, Goo Lee, Sameer Al. Diffalha, Chirag Patel, Upender Manne, Michael Behring, Shefali Chopra, Shuko Harada
Publikováno v:
Human Pathology. 135:108-116
Publikováno v:
Clinics in Laboratory Medicine. 42:385-394
Molecular testing is now considered the standard of care to screen for disease, confirm the diagnosis, guide management, and use target therapy. Currently, several testing strategies are being used. One of the most common strategies is single-gene te
Autor:
A. Craig Mackinnon, Colin M. Johnson, Adam Robin, Lyle Christiansen, Mehenaz Hanbazazh, Rebekah M. Summey, Darshan Chandrashaker, Shuko Harada, Williams H. Bradley
Publikováno v:
Human Pathology.
Autor:
Brooke B. Bartow, Gene P. Siegal, Ceren Yalniz, Ahmed M. Elkhanany, Lei Huo, Qingqing Ding, Aysegul A. Sahin, Hua Guo, Cristina Magi-Galluzzi, Shuko Harada, Xiao Huang
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2524
Poly (adenosine diphosphate-ribose) polymerase inhibitors (PARPis) have demonstrated antitumor activity in cancers with a homologous recombination deficiency (HRD) and have recently been approved by the FDA for the treatment of germline BRCA1/2-mutat
Autor:
Ichiro Nakano, Concettina La Motta, Bakhos A. Tannous, Richard A. Cerione, Shuko Harada, Joshua D. Bernstock, Vito Coviello, Shinobu Yamaguchi, Ahmed N. Ibrahim, Mutsuko Minata, Daisuke Yamashita
Kaplan Meier survival analysis of mice using MDA-468 cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6152f4f8e97938d5696d804dd29ad4b3
https://doi.org/10.1158/1535-7163.22520662
https://doi.org/10.1158/1535-7163.22520662
Autor:
Ichiro Nakano, Concettina La Motta, Bakhos A. Tannous, Richard A. Cerione, Shuko Harada, Joshua D. Bernstock, Vito Coviello, Shinobu Yamaguchi, Ahmed N. Ibrahim, Mutsuko Minata, Daisuke Yamashita
Elevation of ALDH1A3 expression in BM tissues and cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a67a2bb07a248a4e5dd8018529cee29
https://doi.org/10.1158/1535-7163.22520671.v1
https://doi.org/10.1158/1535-7163.22520671.v1